Skip to main content
Signal8

Edwards Larry Todd

SEC insider (Form 3/4/5 filer). CIK 0001994805. Chief Commercial Officer at Oruka Therapeutics, Inc. (ORKA) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Aug 24, 2026. Located in MENLO PARK, CA.

Companies Edwards Larry Todd has filed insider reports for

  • Oruka Therapeutics, Inc. (ORKA): Officer, Chief Commercial Officer
  • Arcutis Biotherapeutics, Inc. (ARQT): Officer, See Remarks
Edwards Larry Todd profile photo

Edwards Larry Todd

CIK: 0001994805

Transaction Breakdown

Open Market Buys (P)1 (7.1%)

High conviction signal

Open Market Sales (S)9 (64.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Oruka Therapeutics, Inc. logo
ORKA

Oruka Therapeutics, Inc.

Officer
Arcutis Biotherapeutics, Inc. logo
ARQT

Arcutis Biotherapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Aug 24, 2026
    Award
    Direct
    100K shares-
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Mar 2, 2026
    Sale
    Direct
    3.6K shares at avg. $25.16$90K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Mar 2, 2026
    Sale
    Direct
    103 shares at avg. $25.91$3K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Feb 27, 2026
    Award
    Direct
    30K shares-
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Feb 2, 2026
    Sale
    Direct
    2.1K shares at avg. $25.50$52K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Nov 6, 2025
    Sale
    Direct
    29.1K shares at avg. $25.16$733K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Oct 2, 2025
    Sale
    Direct
    4.2K shares at avg. $19.99$84K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Oct 2, 2025
    Sale
    Direct
    297 shares at avg. $20.78$6K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    May 19, 2025
    Sale
    Direct
    7.5K shares at avg. $14.07$105K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Feb 28, 2025
    Award
    Direct
    38K shares-

1-10 of 14